Biochemical diagnosis of myocardial infarction evolves towards ESC/ACC consensus: Experiences from the Nordic countries

Scandinavian Cardiovascular Journal

Volumn 39, Issue 3, 2005, Pages 159-166

  Hjortshøj, Søren ^a   Otterstad, Jan Erik ^b   Lindahl, Bertil ^c   Danielsen, Ragnar ^d   Pulkki, Kari ^e   Ravkilde, Jan ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b Vestfold Central Hospital   (Norway)

^c UPPSALA CLINICAL RESEARCH CENTER   (Sweden)

^d Hjartadeild Landspitala Hringbraut   (Iceland)

^e HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Cardiac markers; Harmonization; Myocardial infarction; Periprocedural; Survey

Indexed keywords

ASPARTATE AMINOTRANSFERASE; CREATINE KINASE; MYOGLOBIN; TROPONIN I; TROPONIN T;

ARTICLE; CHEMICAL ANALYSIS; CONSENSUS; CORONARY ARTERY BYPASS GRAFT; DEMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DISEASE MARKER; FINLAND; HEALTH SURVEY; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; QUESTIONNAIRE; SWEDEN;

EID: 27844432363     PISSN: 14017431     EISSN: 16512006     Source Type: Journal    
DOI: 10.1080/14017430510009140     Document Type: Article

References (26)

1. Abedini S, Nielsen OW, Sajadieh A, Sigurd BM. [Diagnosis of acute myocardial infarction in Denmark]. Ugeskr Laeger. 1999;16:5165-8.
2. Agert G, Nilsson G. [What is a myocardial infarction? Technical diagnosis is varying between different hospitals. Quality comparisons require uniformity]. Lakartidningen. 1995;92:381-5.
3. Fretland S, Kruger O. [Differences in diagnostic criteria for acute myocardial ischemia at Norwegian hospitals]. Tidsskr Nor Laegeforen. 1997;117:817-9.
4. Jernberg T, Lindahl B, Wallentin L. [Uniform diagnosis of myocardial infarction. Rapid development at Swedish hospitals]. Lakartidningen. 1998;95:515-20.
5. Nomenclature and criteria for diagnosis of ischemic heart disease. Report of the Joint International Society and Federation of Cardiology/World Health Organization task force on standardization of clinical nomenclature. Circulation. 1979;59:607-9.
6. Hamm CW, Ravkilde J, Gerhardt W, Jorgensen P, Peheim E, Ljungdahl L, et al. The prognostic value of serum troponin T in unstable angina. N Engl J Med. 1992;327:146-50.
7. Ravlkilde J, Nissen H, Horder M, Thygesen K. Independent prognostic value of serum creatine kinase isoenzyme MB mass, cardiac troponin T and myosin light chain levels in suspected acute myocardial infarction. Analysis of 28 months of follow-up in 196 patients. J Am Coll Cardiol. 1995;25: 574-81.
8. Stubbs P, Collinson P, Moseley D, Greenwood T, Noble M. Prognostic significance of admission troponin T concentrations in patients with myocardial infarction. Circulation. 1996;94:1291-7.
9. Wallentin L, Lagerqvist B, Husted S, Kontny F, Stahle E, Swahn E. Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: The FRISC II invasive randomised trial. FRISC II Investigators. Fast Revascularisation during Instability in Coronary artery disease. Lancet. 2000;356:9-16.
10. Myocardial infarction redefined - a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. Eur Heart J. 2000;21:1502-13.
11. Jaffe AS, Ravkilde J, Roberts R, Naslund U, Apple FS, Galvani M, et al. It's time for a change to a troponin standard. Circulation. 2000;102:1216-20.
12. Kontos MC, Fritz LM, Anderson FP, Tatum JL, Ornato JP, Jesse RL. Impact of the troponin standard on the prevalence of acute myocardial infarction. Am Heart J. 2003;146:446-52.
13. Tunstall-Pedoe H. Comment on the ESC/ACC redefinition of myocardial infarction by a consensus dissenter. Eur Heart J. 2001;22:613-6.
14. Hasdai D, Behar S, Boyko V, Danchin N, Bassand JP, Battler A. Cardiac biomarkers and acute coronary syndromes - the Euro Heart Survey of Acute Coronary Syndromes Experience. Eur Heart J. 2003;24:1189-94.
15. Labugger R, Organ L, Collier C, Atar D, Van Eyk JE. Extensive troponin I and T modification detected in serum from patients with acute myocardial infarction. Circulation. 2000;102:1221-6.
16. Lindahl B, Diderholm E, Lagerqvist B, Venge P, Wallentin L. Mechanisms behind the prognostic value of troponin T in unstable coronary artery disease: A FRISC II substudy. J Am Coll Cardiol. 2001;38:979-86.
17. Apple FS, Wu AH, Jaffe AS. European Society of Cardiology and American College of Cardiology guidelines for redefinition of myocardial infarction: How to use existing assays clinically and for clinical trials. Am Heart J. 2002;144: 981-6.
18. Venge P, Lagerqvist B, Diderholm E, Lindahl B, Wallentin L. Clinical performance of three cardiac troponin assays in patients with unstable coronary artery disease (a FRISC II substudy). Am J Cardiol. 2002;89:1035-41.
19. Venge P, Lindahl B, Wallentin L. New generation cardiac troponin I assay for the access immunoassay system. Clin Chem. 2001;47:959-61.
20. Brener SJ, Lytle BW, Schneider JP, Ellis SG, Topol EJ. Association between CK-MB elevation after percutaneous or surgical revascularization and three-year mortality. J Am Coll Cardiol. 2002;40:1961-7.
21. Kini AS, Lee P, Marmur JD, Agarwal A, Duffy ME, Kim MC, et al. Correlation of postpercutaneous coronary intervention creatine kinase-MB and troponin I elevation in predicting mid-term mortality. Am J Cardiol. 2004;93:18-23.
22. Nageh T, Sherwood RA, Harris BM, Byrne JA, Thomas MR. Cardiac troponin T and I and creatine kinase-MB as markers of myocardial injury and predictors of outcome following percutaneous coronary intervention. Int J Cardiol. 2003; 92:285-93.
23. Svedjeholm R, Dahlin LG, Lundberg C, Szabo Z, Kagedal B, Nylander E, et al. Are electrocardiographic Q-wave criteria reliable for diagnosis of perioperative myocardial infarction after coronary surgery? Eur J Cardiothorac Surg. 1998; 13:655-61.
24. Crescenzi G, Bove T, Pappalardo F, Scandroglio AM, Landoni G, Aletti G, et al. Clinical significance of a new Q wave after cardiac surgery. Eur J Cardiothorac Surg. 2004;25: 1001-5.
25. Jaffe AS, Katus H. Acute coronary syndrome biomarkers: The need for more adequate reporting. Circulation. 2004; 110:104-6.
26. Panteghini M, Pagani F, Yeo KT, Apple FS, Christenson RH, Dati F, et al. Evaluation of imprecision for cardiac troponin assays at low-range concentrations. Clin Chem. 2003;50: 327-32.